Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells.
Multipotent mesenchymal stem cells (MSCs) are recently found to alter the tumor condition. However their exact role in tumor development is not yet fully unraveled. MSCs were established to perform many of their actions through paracrine effect. Thus investigation of MSC secretome interaction with tumor cells may provide important information for scientists who are attempting to apply stem cells in the treatment of the disease. In this study we investigated the effect of human Wharton's jelly derived MSC (WJ-MSCs) secretome on proliferation, apoptotic potential of A549 lung cancer cells, and their response to the chemotherapeutic agent doxorubicin. WJ-MSCs were isolated from human umbilical cord and then characterized according to the International Society for Cellular Therapy criteria and WJ-MSC secretome was collected. BrdU cell proliferation assay and Annexin V-PI staining were used for the evaluation of cytotoxic and proapoptotic effects of WJ-MSC secretome on A549 cells. WJ-MSC secretome neither induced proliferation of lung cancer cells nor affected the apoptotic potential of the tumor cells. We also studied the combinatorial effect of WJ-MSC secretome and the anticancer drug doxorubicinwhich showed no induction of drug resistance when A549 cells was treated with combination of WJ-MSC secretome and doxorubicin. Although MSCs did not show antitumor properties, our in vitro results showed that MSC secretome was not tumorigenic and also did not make lung cancer cells resistant to doxorubicin. Thus MSC secretome could be considered safe for other medical purposes such as cardiovascular, neurodegenerative, and autoimmune diseases which may exist or occur in cancer patients.
Department of pharmaceutical biotechnology and Isfahan Pharmaceutical Sciences Research Centre, School of pharmacy and pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
F
F
Hendijani
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Sh Haghjooy
ShH
Javanmard
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
L
L
Rafiee
Department of pharmaceutical biotechnology and Isfahan Pharmaceutical Sciences Research Centre, School of pharmacy and pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
H
H
Sadeghi-Aliabadi
A549 lung cancer cells; Mesenchymal stem cells; Secretome